Pharming Group (PHAR) Short Interest Ratio & Short Volume $10.49 +0.47 (+4.69%) Closing price 03:50 PM EasternExtended Trading$10.52 +0.03 (+0.29%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Pharming Group Short Interest DataPharming Group (PHAR) has a short interest of 1,600 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 6,509 shares to cover all short positions.Current Short Interest1,600 sharesPrevious Short Interest1,600 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$14,032.00Short Interest Ratio0.3 Days to CoverLast Record DateApril 30, 2025Outstanding Shares68,031,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume2,459 sharesAverage Trading Volume6,509 sharesToday's Volume Vs. Average38% Short Selling Pharming Group? Sign up to receive the latest short interest report for Pharming Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPHAR Short Interest Over TimePHAR Days to Cover Over TimePHAR Percentage of Float Shorted Over Time Pharming Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20251,600 shares $14,032.00 No ChangeN/A0.3 $8.77 4/15/20251,600 shares $12,880.00 -36.0%0.0%0.3 $8.05 3/31/20252,500 shares $21,200.00 -56.9%0.0%0.4 $8.48 3/15/20255,800 shares $50,866.00 +107.1%0.0%0.9 $8.77 2/28/20252,800 shares $24,402.00 -47.2%0.0%0.4 $8.72 2/15/20255,300 shares $48,394.30 -29.3%0.0%0.8 $9.13 1/31/20257,500 shares $65,700.00 -68.4%N/A1 $8.76 1/15/202523,700 shares $222,306.00 -8.5%N/A3.4 $9.38 12/31/202425,900 shares $260,554.00 +149.0%N/A3.9 $10.06 12/15/202410,400 shares $93,415.92 -48.8%N/A1.4 $8.98 Get the Latest News and Ratings for PHAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. 11/30/202420,300 shares $149,205.00 -20.4%N/A2.9 $7.35 11/15/202425,500 shares $208,590.00 +165.6%N/A3.9 $8.18 10/31/20249,600 shares $85,536.00 +5.5%N/A1.5 $8.91 10/15/20249,100 shares $79,170.00 +122.0%N/A1.2 $8.70 9/30/20244,100 shares $33,825.00 +17.1%N/A0.6 $8.25 9/15/20243,500 shares $26,250.00 +600.0%N/A0.6 $7.50 8/31/2024500 shares $3,845.00 No ChangeN/A0.1 $7.69 8/15/2024500 shares $3,805.00 -87.5%N/A0.1 $7.61 7/31/20244,000 shares $34,200.00 +14.3%N/A0.6 $8.55 7/15/20243,500 shares $30,485.00 +20.7%N/A0.8 $8.71 6/30/20242,900 shares $24,215.00 -63.8%N/A0.6 $8.35 6/15/20248,000 shares $68,800.00 -22.3%N/A1.8 $8.60 5/31/202410,300 shares $94,245.00 +32.1%N/A2.8 $9.15 5/15/20247,800 shares $74,802.00 +100.0%N/A2.9 $9.59 4/30/20243,900 shares $36,621.00 +200.0%N/A1.4 $9.39 4/15/20241,300 shares $13,273.00 -13.3%N/A0.5 $10.21 3/31/20241,500 shares $16,260.00 -44.4%N/A0.6 $10.84 3/15/20242,700 shares $30,996.00 -10.0%N/A1.2 $11.48 2/29/20243,000 shares $34,350.00 +900.0%N/A1.3 $11.45 2/15/2024300 shares $3,315.00 -72.7%N/A0.2 $11.05 1/31/20241,100 shares $14,025.00 +57.1%N/A0.7 $12.75 1/15/2024700 shares $9,030.00 -30.0%N/A0.3 $12.90 12/31/20231,000 shares $11,430.00 +100.0%N/A0.4 $11.43 12/15/2023500 shares $5,900.00 -16.7%N/A0.2 $11.80 11/30/2023600 shares $6,738.00 +500.0%N/A0.2 $11.23 11/15/2023100 shares $1,147.00 -80.0%N/A0 $11.47 10/31/2023500 shares $5,800.00 -44.4%N/A0.1 $11.60 10/15/2023900 shares $10,800.00 -91.6%N/A0.3 $12.00 9/30/202310,700 shares $121,980.00 +269.0%N/A3.1 $11.40 9/15/20232,900 shares $39,150.00 +7.4%N/A1 $13.50Trump’s Bitcoin Reserve is No Accident… (Ad)Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…Just click here to get all the details on this crypto coin now 8/31/20232,700 shares $34,006.50 +68.8%N/A1.3 $12.60 8/15/20231,600 shares $19,206.72 +33.3%N/A0.7 $12.00 7/31/20231,200 shares $14,400.00 +300.0%N/A0.5 $12.00 7/15/2023300 shares $3,660.00 -76.9%N/A0.1 $12.20 6/30/20231,300 shares $15,145.00 -60.6%N/A0.3 $11.65 6/15/20233,300 shares $40,623.00 +17.9%N/A0.1 $12.31 5/31/20232,800 shares $33,600.00 +180.0%N/A0.1 $12.00 5/15/20231,000 shares $11,610.00 -37.5%N/A0 $11.61 4/30/20231,600 shares $17,792.00 -68.6%N/A0.1 $11.12 4/15/20235,100 shares $58,318.50 -68.5%N/A0.2 $11.44 3/31/202316,200 shares $218,700.00 +1,700.0%N/A0.7 $13.50 3/15/2023900 shares $10,971.00 -55.0%N/A0.1 $12.19 2/28/20232,000 shares $24,440.00 -33.3%N/A0.5 $12.22 2/15/20233,000 shares $39,390.00 +500.0%N/A0.6 $13.13 1/31/2023500 shares $6,685.00 +150.0%N/A0.1 $13.37 1/15/2023200 shares $2,688.00 -85.7%N/A0 $13.44 12/30/20221,400 shares $15,442.00 -60.0%N/A0.2 $11.03 12/15/20223,500 shares $39,725.00 +52.2%N/A0.5 $11.35 11/30/20222,300 shares $28,658.00 No ChangeN/A0.3 $12.46 11/15/20222,300 shares $26,887.00 -11.5%N/A0.3 $11.69 10/31/20222,600 shares $25,194.00 -45.8%N/A0.4 $9.69 10/15/20224,800 shares $44,400.00 +182.4%N/A0.9 $9.25 9/30/20221,700 shares $16,728.00 -62.2%N/A0.3 $9.84 9/15/20224,500 shares $52,650.00 -56.7%N/A1.6 $11.70 8/31/202210,400 shares $125,944.00 +1,055.6%N/A3.3 $12.11 8/15/2022900 shares $9,873.00 +12.5%N/A0.3 $10.97 7/31/2022800 shares $6,092.64 -46.7%N/A0.3 $7.62 7/15/20221,500 shares $10,896.45 -42.3%N/A0.4 $7.26 6/30/20222,600 shares $22,776.00 -36.6%N/A0.7 $8.76 6/15/20224,100 shares $29,520.00 +215.4%N/A0.9 $7.20 5/31/20221,300 shares $10,569.00 -35.0%N/A0.3 $8.13 5/15/20222,000 shares $16,099.80 No ChangeN/A0.4 $8.05 4/30/20222,000 shares $16,604.40 -23.1%N/A0.4 $8.30 4/15/20222,600 shares $24,005.02 -36.6%N/A0.5 $9.23 3/31/20224,100 shares $36,859.00 +5.1%N/A0.8 $8.99 3/15/20223,900 shares $31,980.39 -29.1%N/A0.8 $8.20 2/28/20225,500 shares $50,875.00 -1.8%N/A1.1 $9.25 2/15/20225,600 shares $53,648.00 -45.1%N/A1.1 $9.58 1/31/202210,200 shares $91,494.00 +2.0%N/A1.6 $8.97 1/15/202210,000 shares $92,600.00 -33.3%N/A1 $9.26 12/31/202115,000 shares $134,100.00 +200.0%N/A1.5 $8.94 12/15/20215,000 shares $41,800.00 +2.0%N/A0.5 $8.36 11/30/20214,900 shares $39,396.00 -38.0%N/A0.6 $8.04 11/15/20217,900 shares $71,653.00 +14.5%N/A1 $9.07 10/29/20216,900 shares $62,100.00 -28.1%N/A1 $9.00 10/15/20219,600 shares $90,624.00 +966.7%N/A9.6 $9.44 9/30/2021900 shares $8,550.00 +350.0%N/A1 $9.50 9/15/2021200 shares $1,940.00 -77.8%N/A0.2 $9.70 8/31/2021900 shares $9,945.00 +350.0%N/A0.7 $11.05 8/13/2021200 shares $2,108.00 No ChangeN/A0.1 $10.54Gold Hits New Highs as Global Markets Spiral (Ad)When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.Go Here to Learn What's Happening and How to Prepare >> 5/28/20217,900 shares $95,985.00 -11.2%N/A3 $12.15 5/14/20218,900 shares $105,999.00 +17.1%N/A2.2 $11.91 4/30/20217,600 shares $97,432.00 +660.0%N/A1.5 $12.82 4/15/20211,000 shares $13,000.00 -92.3%N/A0.2 $13.00 3/31/202112,900 shares $167,958.00 -65.6%N/A1.7 $13.02 3/15/202137,500 shares $503,625.00 +229.0%N/A1.2 $13.43 2/26/202111,400 shares $154,584.00 -5.8%N/A0.3 $13.56 2/12/202112,100 shares $168,069.00 +450.0%N/A0.3 $13.89 1/29/20212,200 shares $32,120.00 +57.1%N/A0 $14.60 1/15/20211,400 shares $19,320.00 No ChangeN/A0 $13.80 PHAR Short Interest - Frequently Asked Questions What is Pharming Group's current short interest? Short interest is the volume of Pharming Group shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,600 shares of PHAR short. Learn More on Pharming Group's current short interest. How does Pharming Group's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Pharming Group: MoonLake Immunotherapeutics (11.52%), Immunovant, Inc. (30.43%), HUTCHMED (China) Limited (0.24%), Amneal Pharmaceuticals, Inc. (4.44%), Organon & Co. (7.61%), Mirum Pharmaceuticals, Inc. (12.58%), Apellis Pharmaceuticals, Inc. (22.89%), Vericel Co. (9.18%), NewAmsterdam Pharma (8.68%), Kymera Therapeutics, Inc. (11.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Pharming Group stock? Short selling PHAR is an investing strategy that aims to generate trading profit from Pharming Group as its price is falling. PHAR shares are trading up $0.47 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pharming Group? A short squeeze for Pharming Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PHAR, which in turn drives the price of the stock up even further. How often is Pharming Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PHAR, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies MoonLake Immunotherapeutics Short Squeeze Immunovant Short Squeeze HUTCHMED Short Squeeze Amneal Pharmaceuticals Short Squeeze Organon & Co. Short Squeeze Mirum Pharmaceuticals Short Squeeze Apellis Pharmaceuticals Short Squeeze Vericel Short Squeeze NewAmsterdam Pharma Short Squeeze Kymera Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PHAR) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PHAR Stock Free PHAR Stock Alerts